未登录 Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses 曲妥珠单抗德鲁替康在DESTINY-PanTumor02研究中对HER2表达妇科癌症的抗肿瘤活性、安全性和探索性生物标志物分析 Lee, Jung-Yun; Oaknin, Ana; Manso, Luis; Gonzalez-Martin, Antonio; Lugowska, Iwona; Lorusso, Domenica; Banerjee, Susana; Liao, John B.; Lu, Chien-Hsing; Prasongsook, Naiyarat; Melichar, Bohuslav; Anoka, Chiedozie; Jung, Lindsey; Michelini, Flavia; Puvvada, Soham; Meric-Bernstam, Funda; Makker, Vicky 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02 研究总结: 通过招募HER2 IHC状态: DESTINY-PanTumor02的事后分析，曲妥珠单抗Deruxtecan在HER2-Expressing实体瘤中的疗效 Oaknin, Ana; Lee, Jung-Yun; Makker, Vicky; Oh, Do-Youn; Banerjee, Susana; Gonzalez-Martin, Antonio; Jung, Kyung Hae; Lugowska, Iwona; Manso, Luis; Manzano, Aranzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Puvvada, Soham; Smith, Ann; Meric-Bernstam, Funda 分享 收藏
Incorporating immune checkpoint inhibitors in epithelial ovarian cancer 将免疫检查点抑制剂应用于上皮性卵巢癌 Bogani, Giorgio; Moore, Kathleen N.; Ray-Coquard, Isabelle; Lorusso, Domenica; Matulonis, Ursula A.; Ledermann, Jonathan A.; Gonzalez-Martin, Antonio; Kurtz, Jean-Emmanuel; Pujade-Lauraine, Eric; Scambia, Giovanni; Caruso, Giuseppe; Raspagliesi, Francesco; Colombo, Nicoletta; Monk, Bradley J. 分享 收藏
SUROVA Study: Global Real-World Treatment Strategies And Mortality Risk Prediction In Advanced Ovarian Cancer SUROVA研究：晚期卵巢癌全球真实世界治疗策略与死亡风险预测 Chiva, Luis; Ordas, Pilar; Mishra, Jagannath; Ayhan, Ali; Lee, Yoo-Young; Bogani, Giorgio; Somashekhar, S. P.; Lomnytska, Marta; Stukan, Maciej; Fruscio, Robert; Chura, Bernabe Fora; Salcedo-Hernandez, Rosa A.; De Iaco, Pierandrea; Haidopoulos, Dimitrios; Svintsitskiy, Valentyn; Jain, Vandana; Stanciu, Paul; Rawert, Friederike Luise; Akdemir, Celal; Abdallah, Reem; Chacon, Enrique; Minguez, Jose Angel; Gil-Moreno, Antonio; Kharchenko, Kateryna; Mofrad, Malihe Hasanzadeh; Gebauer, Gerhard; Diaz-Feijoo, Berta; Scibilia, Giuseppe; Klaric, Marko; Skof, Erik; Abu Saadeh, Feras; Mueller, Michael D.; Saarelainen, Sami; Garcia, alvaro Tejerizo; Fotopoulou, Christina; Gonzalez-Martin, Antonio 分享 收藏
Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80) Dodarlimab单独或联合贝伐单抗与非铂类化疗在复发性妇科透明细胞癌中的II期随机研究 (DOVE/APGOT-OV7/ENGOT-ov80) Lee, Jung-Yun; Tan, David; Ray-Coquard, Isabelle; Lee, Jung Bok; Kim, Byoung Gie; Van Nieuwenhuysen, Els; Huang, Ruby Yun-Ju; Tse, Ka Yu; Gonzalez-Martin, Antonio; Scott, Clare; Hasegawa, Kosei; Wilkinson, Katie; Yang, Eun Yeong; Lheureux, Stephanie; Kristeleit, Rebecca 分享 收藏
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ ENGOT-OV26/GOG-3012 trial 新诊断晚期卵巢癌患者的尼拉帕尼一线维持治疗: PRIMA/ ENGOT-OV26/GOG-3012试验的最终总生存期结果 Monk, B. J.; Barretina-Ginesta, M. P.; Pothuri, B.; Vergote, I.; Graybill, W.; Mirza, M. R.; Mccormicky, C. C.; Lorusso, D.; Moore, R. G.; Freyer, G.; O'Cearbhaill, R. E.; Heitz, F.; O'Malley, D. M.; Redondo, A.; Shahin, M. S.; Vulsteke, C.; Bradley, W. H.; Haslund, C. A.; Chase, D. M.; Pisano, C.; Holman, L. L.; Perez, M. J. Rubio; Disilvestro, P.; Gaba, L.; Herzog, T. J.; Bruchim, I.; Compton, N.; Shtessel, L.; Malinowska, I. A.; Gonzalez-Martin, A. 分享 收藏
Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02 通过纳入HER2 IHC状态: DESTINY-PanTumor02的事后分析，曲妥珠单抗Deruxtecan在HER2-Expressing实体瘤中的疗效 Oaknin, Ana; Lee, Jung-Yun; Makker, Vicky; Oh, Do-Youn; Banerjee, Susana; Gonzalez-Martin, Antonio; Jung, Kyung Hae; Lugowska, Iwona; Manso, Luis; Manzano, Aranzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Puvvada, Soham; Smith, Ann; Meric-Bernstam, Funda 分享 收藏
Tolerability of the niraparib individualized starting dose in the PRIMA/ ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy 尼拉帕利一线维持治疗的PRIMA/ ENGOT-OV26/GOG-3012试验中尼拉帕利个体化起始剂量的耐受性 Vulsteke, Christof; Chambers, Setsuko K.; Perez, Maria Jesus Rubio; Chan, John K.; Raaschou-Jensen, Nicoline; Zhuo, Ying; Lorusso, Domenica; Herzog, Thomas J.; Rouge, Thibault de la Motte; Pepin, Jessica A. Thomes; Braicu, Elena Ioana; Chen, Lee-may; Levy, Tally; Barter, James F.; Barretina-Ginesta, M. Pilar; Joosens, Eric; York, Whitney; Malinowska, Izabela A.; Gonzalez-Martin, Antonio; Monk, Bradley J. 分享 收藏
Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer Monk, Bradley J.; Romero, Ignacio; Graybill, Whitney; Churruca, Cristina; O'Malley, David M.; Knudsen, Anja or; Yap, Oi Wah Stephanie; Baurain, Jean-Francois; Rose, Peter G.; Denys, Hannelore; Ghamande, Sharad; Pisano, Carmela; Fabbro, Michel; Braicu, Elena Ioana; Calvert, Paula M.; Amit, Amnon; Prendergast, Emily; Taylor, Adekemi; Kheibarshekan, Leila; Zhang, Zhi-Yi; Zajic, Stefan; Jewell, Roxanne C.; Gupta, Divya; Gonzalez-Martin, Antonio 分享 收藏
分享 收藏
Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study 在真实世界中，对接受trabectedin和聚乙二醇化脂质体阿霉素 (pld) 治疗的铂敏感复发性卵巢癌老年患者的回顾性多中心研究: geico研究 Rubio, Maria Jesus; Manzano, Aranzazu; de Sande, Luis Miguel; Estevez-Garcia, Purificacion; Gordon, Maria del Mar; de Prado, Diego Soto; de Aranguiz, Blanca Hernando Fernandez; Guerra-Alia, Eva M.; Carbo-Bague, Anna; Romero, Ignacio; Corbellas, Miguel; Gonzalez-Haba, Alba; Robles-Barraza, Carlos E.; Martinez-Garcia, Jeronimo; Gonzalez-Martin, Antonio 分享 收藏
Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer 低覆盖率全基因组检测卵巢癌同源重组缺陷的临床评价 Boidot, Romain; Blum, Michael G. B.; Wissler, Marie-Pierre; Gottin, Celine; Ruzicka, Jiri; Chevrier, Sandy; Delhomme, Tiffany M.; Audoux, Jerome; Jeanniard, Adrien; Just, Pierre-Alexandre; Harter, Philipp; Pignata, Sandro; Gonzalez-Martin, Antonio; Marth, Christian; Maenpaa, Johanna; Colombo, Nicoletta; Vergote, Ignace; Fujiwara, Keiichi; Duforet-Frebourg, Nicolas; Bertrand, Denis; Philippe, Nicolas; Ray-Coquard, Isabelle; Pujade-Lauraine, Eric 分享 收藏
Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - a plain language summary 随访3.5年时的无进展生存期和安全性: 对新诊断卵巢癌患者进行尼拉帕尼维持治疗的3期PRIMA/ENGOT-OV26/GOG-3012随机试验的结果-简明语言总结 Gonzalez-Martin, Antonio; Pothuri, Bhavana; Vergote, Ignace; Graybill, Whitney; Lorusso, Domenica; McCormick, Colleen C.; Freyer, Gilles; Backes, Floor; Heitz, Florian; Redondo, Andres; Moore, Richard G.; Vulsteke, Christof; O'Cearbhaill, Roisin E.; Malinowska, Izabela A.; Shtessel, Luda; Compton, Natalie; Mirza, Mansoor R.; Monk, Bradley J. 分享 收藏
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease ESGO-ESMO-ESP共识会议关于卵巢癌的建议: 病理学和分子生物学以及早期，晚期和复发性疾病 Ledermann, J. A.; Matias-Guiu, X.; Amant, F.; Concin, N.; Davidson, B.; Fotopoulou, C.; Gonzalez-Martin, A.; Gourley, C.; Leary, A.; Lorusso, D.; Banerjee, S.; Chiva, L.; Cibula, D.; Colombo, N.; Croce, S.; Eriksson, A. G.; Falandry, C.; Fischerova, D.; Harter, P.; Joly, F.; Lazaro, C.; Lok, C.; Mahner, S.; Marme, F.; Marth, C.; McCluggage, W. G.; Mcneish, I. A.; Morice, P.; Nicum, S.; Oaknin, A.; Perez-Fidalgo, J. A.; Pignata, S.; Ramirez, P. T.; Ray-Coquard, I.; Romero, I.; Scambia, G.; Sehouli, J.; Shapira-Frommer, R.; Sundar, S.; Tan, D. S. P.; Taskiran, C.; van Driel, W. J.; Vergote, I.; Planchamp, F.; Sessa, C.; Fagotti, A. 分享 收藏
GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profiles Pozzorini, Christian; Andre, Gregoire; Coletta, Tommaso; Buisson, Adrien; Bieler, Jonathan; Ferrer, Loic; Kempfer, Rieke; Saintigny, Pierre; Harle, Alexandre; Vacirca, Davide; Barberis, Massimo; Gilson, Pauline; Roma, Cristin; Saitta, Alexandra; Smith, Ewan; Barras, Floriane Consales; Ripol, Lucia; Fritzsche, Martin; Marques, Ana Claudia; Alkodsi, Amjad; Marin, Ray; Normanno, Nicola; Grimm, Christoph; Mullauer, Leonhard; Harter, Philipp; Pignata, Sandro; Gonzalez-Martin, Antonio; Denison, Ursula; Fujiwara, Keiichi; Vergote, Ignace; Colombo, Nicoletta; Willig, Adrian; Pujade-Lauraine, Eric; Just, Pierre-Alexandre; Ray-Coquard, Isabelle; Xu, Zhenyu 分享 收藏
Trastuzumab deruxtecan (T-DXd) for pretreated patients (pts) with HER2-expressing solid tumors: Primary analysis from the DESTINY-PanTumor02 (DP-02) study Oh, D-Y.; Meric-Bernstam, F.; Makker, V.; Oaknin, A.; Banerjee, S.; Gonzalez Martin, A.; Jung, K. H.; Lugowska, I.; Manso, L. M.; Manzano, A.; Melichar, B.; Siena, S.; Stroyakovskiy, D.; Fielding, A.; Ma, Y.; Puvvada, S. D.; Lee, J-Y. 分享 收藏
InnovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator's choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer Fujiwara, K.; Slomovitz, B. M.; Gonzalez Martin, A.; Kalbacher, E.; Bagameri, A.; Ghamande, S.; Lee, J-Y.; Banerjee, S.; Maluf, F. C.; Lorusso, D.; Yonemori, K.; van Nieuwenhuysen, E.; Manso Sanchez, L. M.; Woelber, L.; Westermann, A. M.; Covens, A.; Whalley, E.; Teng, M. S. L.; Soumaoro, I.; Vergote, I. B. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
.png){kind=icon}
分享.png){kind=icon}
收藏.png)
BMC CANCER
OAAI